Viglya is a consulting firm which provides guidance to bio- and pharmaceutical companies in the area of life science, specializing in drug development strategy, regulatory affairs, and pharmacovigilance during all clinical phases and life cycle follow-up. We also provide related services, such as quality system implementation, auditing, and training.
|Headquarters||C/Casanova 264, Ppal. 2a 08021 Barcelona Spain|
|Key people||Marie-Dominique Mompas - founder|
Founded in 2012.
Marie-Dominique Mompas is the founder of Viglya. She studied Pharmaceutical Science at the Université Paris-Sud in France and she holds both a doctorate degree in Pharmacy (PharmD) and a Master’s Degree in international law from the same university. She has worked for more than 18 years in the pharmaceutical industry in both large and small pharmaceutical and biotechnology companies, at different levels of responsibility, in regulatory affairs and pharmacovigilance. This experience has resulted in her extensive knowledge and profound understanding of the international regulatory landscape.
Furthermore, she spent 12 years working in the United States for such multinational companies as Bristol-Myers Squibb and Pfizer, and at biotechnology companies such as Agouron Pharmaceuticals. Her last position in the United States was as Director of Regulatory Strategy at Pfizer where she dealt directly with the FDA for the conduct of clinical programs, the preparation and negotiation of regulatory submissions (CDER), and the management of advertising and promotional activities (DDMAC) for HIV products. Viglya is one's company’s multicultural partner with a global presence through their various partnerships within Europe and the United States. The company’s quality services and results forge solid and long-term relationships with its stakeholders.
The brand name Viglya reflects the company’s main interests: providing professional support in the area of life science; offering top quality, ethical services with enthusiasm; enriching professional relationships with global strategic thinking; and as a result, becoming a preferred partner to our clients.
Origin of the name Viglya:
Vigía comes from the verb vigiler (in French) and vigilar (in Spanish) which means to watch, to keep an eye on, to guard, or to protect. It can also mean the action of discovering an object from afar.
Hygieia (also Hygiea or Hygeia, Greek Hygieía o Hygeía), was one of the daughters of Asclepius, the God of Medicine. She was the personification of health, cleanliness and sanitation. Hygieia is the root of the word hygiene.
Top 5 Recent Tweets
|November 24, 2020||Viglya||#FDA Authorizes First #COVID19 Test for Self-Testing at Home https://t.co/bOcBXt5E0A #ddnewsusfda #ranewsusfda #viglya4growth|
|November 24, 2020||Viglya||#FDA’s Ongoing Commitment to #Transparency for #COVID19 EUAs https://t.co/HUjTXo9sza #ddnewsusfda #ranewsusfda #viglya4growth|
|November 24, 2020||Viglya||UK #MHRA: #Sleepdisorder drug #modafinil linked to increased risk of birth defects and also to reduced effectivenes… https://t.co/CUlPzpm7Nb|
|November 24, 2020||FDAMedia||FDA continues to work toward our Drug Competition Action Plan goals. Today, we finalized a guidance to further supp… https://t.co/BEdnZBeZi2|
|November 24, 2020||Viglya||#EMA starts rolling review of mRNA #COVID19vaccine by #Moderna Biotech Spain, S.L. https://t.co/GEQwDExJjP… https://t.co/DTRjpkISG7|